186RNL for neoplasm metastasis

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 2 Jul 2025: Trial started, NCT07098806
  2. 1 Aug 2025: Trial registered, NCT07098806

The trials

NCT07098806: Multiple Dose Intraventricular Administration of Rhenium-186 NanoLiposome for Leptomeningeal Metastases

State
Under way
Phase
Phase 1 and Phase 2
People
24 planned
Started
2 Jul 2025
Primary completion
31 Jul 2027
Arms
Experimental: Multiple Doses
Results
None posted
  1. 2 Jul 2025: Trial started
  2. 1 Aug 2025: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 1 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.